glp-1/gip receptor agonists GLP1-GIP co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Possible mechanisms of action of
Description
In intestinal L-cells, proglucagon is cleaved by prohormone convertase 1/3 (PC1/3) to generate GLP-1, along with other peptides such as GLP-2, oxyntomodulin, and peptide YY
Pick one time each day to try
Therefore, patients with inadequate or no insurance coverage may have affordability concerns
Murine models of heart failure with preserved ejection fraction: a fishing expedition. JACC Basic Transl Sci
Not every patient wants surgery
Comparative effectiveness of dipeptidylpeptidase-4 inhibitors in type 2 diabetes: a systematic review and mixed treatment comparison
